Mounjaro made $22.9b in 2025, second only to Keytruda, per Kanyi Maqubela
Maqubela's list of 2025 brand revenues puts Ozempic third at $19.2b, ahead of Dupixent and Skyrizi.
Recap by typeshit. Post by Kanyi Maqubela on X.
Maqubela's list of 2025 brand revenues puts Ozempic third at $19.2b, ahead of Dupixent and Skyrizi.
Recap by typeshit. Post by Kanyi Maqubela on X.
A guide covers who qualifies for the lower price, how to bring it up with a doctor, and delivery options that cut costs further.
A Facebook post says Ozempic's Medicare price drops 71% as negotiated rates on 15 drugs, including Wegovy and Trelegy, take effect.
Negotiated Medicare prices on 15 drugs, Ozempic, Wegovy and Trelegy among them, take effect in 2027. The full list of drugs and discounts is at the link.
The rise was driven by new generics and steady prices, with Eli Lilly's tirzepatide named in the market breakdown.
Bloomberg reports the Kennedy plan to widen peptide access comes with a side effect reporting rule for compounding pharmacies.
A Houston Methodist NHANES analysis shown at ASN Kidney Week 2026 found unawareness stayed near 80% to 85% for a decade as the eligible group grew.
Loading…